基因治疗状细胞疾病的信息共享决策或严格的资格和排除标准?
Lakshmanan Krishnamurti1, Ayobami Olafimihan2, Lewis L Hsu3
1Yale University School of Medicine, New Haven, Connecticut, United States.
Blood advances
|October 15, 2025
概括
血造细胞移植 (HCT) 和基因疗法 (GT) 对状细胞疾病 (SCD) 提供了很好的结果. 目前的试验使用了严格的标准,但证据表明,对于严重的血管封闭性发作 (VOE) 具有共享决策的更广泛的应用.
科学领域:
- 血液学 血液学 血液学
- 基因治疗 基因治疗
- 状细胞疾病研究研究
背景情况:
- 血造细胞移植 (HCT) 用于状细胞疾病 (SCD) 历来使用了限制性资格标准,因为早期的高死亡率.
- 这些限制性标准已应用于当前的HCT和基因疗法 (GT) 临床试验,但不包括具有特定并发症的患者.
- 美国食品和药物管理局对复发性血管闭塞发作 (VOE) 的GT的资格缺乏排除标准,促使对临床GT的资格进行重新评估.
研究的目的:
- 在SCD患者中评估HCT和GT的结果.
- 质疑当代HCT和GT试验中继续使用限制性资格标准.
- 基于有效性和以患者为中心的护理的证据,倡导在SCD中更广泛地应用GT.
主要方法:
- 对SCD的HCT和GT的结果数据的综述.
- 对HCT和GT试验的历史和当代资格标准的分析.
- 美国食品和药物管理局的资格标准与临床试验排除标准的比较.
主要成果:
- 来自HLA相同的兄弟捐赠者的HCT和GT在SCD中显示出出色的整体和无事件生存率.
- 观察到与健康相关的生活质量和VOE改善的显著改善.
- 在HCT和GT后注意到脑血管病变的稳定.
结论:
- 在HCT和GT后的优异结果证明了在SCD患者中具有严重VOE的更广泛应用.
- 由患者偏好为指导的共享决策应该是GT资格的核心.
- 承认现有的证据缺口至关重要,同时扩大GT可访问性.
相关概念视频
00:59Gene Therapy
27.3K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.3K
01:49Multiple Allele Traits
37.9K
The Concept of Multiple Allelism
37.9K
01:22iPS Cell Differentiation
3.0K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.0K
01:01Regulation of Hematopoietic Stem Cells
4.0K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.0K
01:28Kidney Transplant I: Introduction
340
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
340
02:50Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K